solid organ growth margin expans lead bottom-lin
maintain market perform rate stryker corpor follow
week releas result anoth solid quarter sale
earn growth continu deliv solid top-lin perform margin
expans high end large-cap med-tech sector organ sale growth
came benefit one sell day adjust ep grew
beat consensu exceed guidanc
rang
despit continu strength current trade ep
estim versu consensu orthoped peer zimmer biomet hold
mo pt slightli averag group select large-
cap med-tech peer therefor believ compani share reflect fair valu
base compar profil
total revenu bln y/i cc organ line
consensu neurotechnolog spine sole segment outperform
respect street estim report sale mln y/i
cc organ versu consensu mln driven neurotech growth
y/i cc organ solid spine improv y/i
cc organ given challeng landscap area strength
includ compani instrument divis benefit roll-out
knee continu see uptick mako well trauma extrem
driven foot ankl platform shoulder portfolio hospit convers
result includ growth increas volum price
guidanc adjust top bottom line call organ
top-lin growth adjust ep y/i
favor fx impact current rate remain unchang updat
expect posit impact previou guidanc set organ
sale growth ep y/i
turn compani segment ortho increas y/i cc
 knee cc hip cc trauma extrem
cc medsurg increas y/i cc
cc sustain cc neurotech spine includ entellu
increas y/i cc driven neurotech
cc spine cc
focus orthoped segment report bln sale y/i
organ growth line consensu continu growth trend
thomson reuter jmp secur llc
compani report jmp secur llc
report read conjunct import disclosur inform includ attest regul analyst certif
past sever quarter mid-to-high single-digit improv report progress mako
robot demand continu seen tka knee platform addit instal robot
total quarter ou compar new system sold
competit account upgrad robot field tka track vast
major complet expect unchang approxim
surgeon train mako tka procedur perform
quarter bring ytd total compani also current collect clinic
data evalu variou outcom mako robot manag expect later
year signific result
manag updat guidanc includ foreign currenc variat ep expect
figur outlin key metric organ sale expect previous
ep set previous
figur follow page contain comparison actual result jmp estim rang
revenu metric along select commentari
guidancecurrentpriordirectionrevenu current level neg impact expect fx impact neutral full year stryker corpor
 bpslarg joint bpstrauma bpssustain bpsneuro bpstotal blnannual bpsgross bpsup bp y/i impact favor product effici off-set price fx mix bpsdown bp y/i driven oper expens improv ctg program focu indirect purchasing/ share servic key product off-set neg impact acquisit plan invest ctg program effort includ erp project certain mako invest bpsup bp mln bpsoper bpstax bpsoper tax rate off-set benefit relat stock compens expensesnet cc core bed strucutr power cot physio product call solid contributor medic busi continu drive recoveri track deliv strong growth remaind softer sale qtr cc growth cc exclud acquisit volum price cc organ exclud cc organc growth despit challeng market backdrop continu see market soft mid-singl digit price declin iv busi tritanium implant product deliv double-digit growth cc sale qtr constant currenc volum price cc growth cc total robot instal ou vast major robot expect upgrad robot instal competitv account surgeon train train util roughli cc foot ankl continu strong grower shoulder also robust growth smaller cc sale qtr cc cc exclud acquisit volum price cc strong perform driven system roll-out still quarter full commerci launch micro power product line somewhat off-set puerto rico suppli issu expect materi impact go forward cc slight slow due tough y/i comp first quarter sinc post double-digit cc growth continu execut novadaq integr stryker corpor
one largest compani med-tech year busi develop activ given compani evolv footprint
span well beyond tradit orthoped line three major sale segment today orthopaed hip knee trauma medsurg
instrument endoscopi medic reprocess neurotech spine neurosurg neurovascular devic tradit metal
implant orthobiolog mainli spine fusion divis complement nice also offer signific divers
multipl way grow grant compani potenti remain balanc time ideal benefit abil off-set
under-perform line stronger devic sale adjac arena
highli diversifi bring posit neg consequ depend upon underli fundament differ
market volum rebound core orthoped arena may occur would like mute impact growth given
sizabl revenu base price like remain headwind across sector med-tech could worsen new product may perform
well anticip acquisit integr could prove challeng expect signific exposur outsid
ou sale meaning exposur europ asia subject compani headwind tailwind may aris
geographi
research analyst prepar report does/do herebi certifi view present report accord my/our
person view secur issuer discuss report mandat sec regul ac part my/our compens
directli indirectli relat specif view recommend express herein certif made
oblig set forth sec regul ac person entiti may use purpos certif made
base my/our analysi date report public i/w assum oblig updat certif reflect fact
circumst event may subsequ come my/our attent sign david turkali daniel stauder
